Literature DB >> 26298280

Development and validation of a direct-comparison method for cardiac (123)I-metaiodobenzylguanidine washout rates derived from late 3-hour and 4-hour imaging.

Koichi Okuda1, Kenichi Nakajima2, Shuichi Sugino3, Yumiko Kirihara4, Shinro Matsuo2, Junichi Taki2, Mitsumasa Hashimoto5, Seigo Kinuya2.   

Abstract

PURPOSE: The washout rate (WR) has been used in (123)I-metaiodobenzylguanidine (MIBG) imaging to evaluate cardiac sympathetic innervation. However, WR varies depending on the time between the early and late MIBG scans. Late scans are performed at either 3 or 4 hours after injection of MIBG. The aim of this study was to directly compare the WR at 3 hours (WR3h) with the WR at 4 hours (WR4h).
METHODS: We hypothesized that the cardiac count would reduce linearly between the 3-hour and 4-hour scans. A linear regression model for cardiac counts at two time-points was generated. We enrolled a total of 96 patients who underwent planar (123)I-MIBG scintigraphy early (15 min) and during the late phase at both 3 and 4 hours. Patients were randomly divided into two groups: a model-creation group (group 1) and a clinical validation group (group 2). Cardiac counts at 15 minutes (countearly), 3 hours (count3h) and 4 hours (count4h) were measured. Cardiac count4h was mathematically estimated using the linear regression model from countearly and count3h.
RESULTS: In group 1, the actual cardiac count4h/countearly was highly significantly correlated with count3h/countearly (r = 0.979). In group 2, the average estimated count4h was 92.8 ± 31.9, and there was no significant difference between this value and the actual count4h (91.9 ± 31.9). Bland-Altman analysis revealed a small bias of -0.9 with 95 % limits of agreement of -6.2 and +4.3. WR4h calculated using the estimated cardiac count4h was comparable to the actual WR4h (24.3 ± 9.6 % vs. 25.1 ± 9.7 %, p = ns). Bland-Altman analysis and the intraclass correlation coefficient showed that there was excellent agreement between the estimated and actual WR4h.
CONCLUSION: The linear regression model that we used accurately estimated cardiac count4h using countearly and count3h. Moreover, WR4h that was mathematically calculated using the estimated count4h was comparable to the actual WR4h.

Entities:  

Keywords:  Cardiac 123I-MIBG imaging; Cardiac sympathetic innervation; Linear regression model; Washout rate

Mesh:

Substances:

Year:  2015        PMID: 26298280     DOI: 10.1007/s00259-015-3173-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  17 in total

1.  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.

Authors:  Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Mitsuhiro Yoshita; Junichi Taki; Masahito Yamada; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

2.  Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.

Authors:  Kenichi Kashihara; Manabu Ohno; Sanami Kawada; Yoshihiro Okumura
Journal:  J Nucl Med       Date:  2006-07       Impact factor: 10.057

3.  Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

Authors:  M Yoshita; J Taki; K Yokoyama; M Noguchi-Shinohara; Y Matsumoto; K Nakajima; M Yamada
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

Review 4.  Cardiac studies with metaiodobenzylguanidine: a critique of methods and interpretation of results.

Authors:  J V Glowniak
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

Review 5.  Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: a review of the literature.

Authors:  Linda van der Veen; Arthur Scholte; Marcel Stokkel
Journal:  Nucl Med Commun       Date:  2010-07       Impact factor: 1.690

6.  [Validation of an optimal analysis method and reproducibility to calculate the heart-to-mediastinum ratio and washout rate in the iodine-123-labeled metaiodobenzylguanidine myocardial scintigraphy].

Authors:  Daisuke Hasegawa; Hideo Onishi; Norikazu Matsutomo; Yoshiharu Kangai
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2014-12

7.  I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients.

Authors:  Mordechai Lorberboym; Yair Lampl; Galina Nikolov; Menachem Sadeh; Ronit Gilad
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

8.  A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.

Authors:  Tomoaki Nakata; Kenichi Nakajima; Shohei Yamashina; Takahisa Yamada; Mitsuru Momose; Shu Kasama; Toshiki Matsui; Shinro Matsuo; Mark I Travin; Arnold F Jacobson
Journal:  JACC Cardiovasc Imaging       Date:  2013-07

9.  Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.

Authors:  Caroline E Veltman; Mark J Boogers; Joris E Meinardi; Imad Al Younis; Petra Dibbets-Schneider; Ernst E Van der Wall; Jeroen J Bax; Arthur J H A Scholte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-13       Impact factor: 9.236

10.  Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations.

Authors:  Kenichi Nakajima; Koichi Okuda; Mana Yoshimura; Shinro Matsuo; Hiroshi Wakabayashi; Yasuhiro Imanishi; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

View more
  5 in total

Review 1.  (123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological Diseases.

Authors:  Kenichi Nakajima; Masahito Yamada
Journal:  Chonnam Med J       Date:  2016-09-23

Review 2.  Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database.

Authors:  Kenichi Nakajima; Naoya Matsumoto; Tokuo Kasai; Shinro Matsuo; Keisuke Kiso; Koichi Okuda
Journal:  Ann Nucl Med       Date:  2016-02-20       Impact factor: 2.668

3.  The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.

Authors:  Aukelien C Dimitriu-Leen; Alessia Gimelli; Imad Al Younis; Caroline E Veltman; Hein J Verberne; Ron Wolterbeek; Silvia Zandbergen-Harlaar; Jeroen J Bax; Arthur J H A Scholte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-29       Impact factor: 9.236

Review 4.  Standardization of 123I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications.

Authors:  Kenichi Nakajima; Derk O Verschure; Koichi Okuda; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2017-05-04

5.  Is 123I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.

Authors:  Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Hiroshi Wakabayashi; Seigo Kinuya
Journal:  Ann Nucl Med       Date:  2018-01-15       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.